SecBot SecBot
SECBOTREPLAY Home › Report › CVS

CVS · In the Generic Pharmaceuticals MDL, Judge Rufe granted in part and…

CVS HEALTH Corp · COURT-RULING filed Mar 1, 2026 at 19:00 ET

At the news

NEUTRALIMPACT 3/10

COURT-RULING filed Mar 1, 2026 at 19:00 ET

In the Generic Pharmaceuticals MDL, Judge Rufe granted in part and denied in part Epic Pharma's motions to dismiss antitrust claims. CVS's complaint against Epic was dismissed for failure to state a claim, as it lacked specific allegations linking Epic to any conspiracy regarding Ursodiol. This is a procedural win for Epic and removes CVS from this particular litigation track, but the ruling is interlocutory and does not resolve the broader MDL.

  • CVS Pharmacy, Inc. v. Actavis Elizabeth, LLC, et al. (2:20-cv-06310) was one of three complaints dismissed against Epic Pharma for failure to state a claim.
  • The court found CVS's complaint lacked any specific act by Epic regarding Ursodiol, no meeting, phone call, or price hike was alleged.
  • Epic's motions to dismiss were denied as to eight other complaints (including those by Kroger, Humana, Rite Aid, Walgreens, UnitedHealth, and others) which sufficiently alleged a conspiracy.
  • The ruling is a motion-to-dismiss decision under Rule 12(b)(6); it does not adjudicate the merits of the broader antitrust conspiracy allegations.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access